Affimed
AFMD
#11136
Rank
โ‚น0.27 B
Marketcap
โ‚น16.82
Share price
0.00%
Change (1 day)
N/A
Change (1 year)

Earnings for Affimed (AFMD)

Earnings in 2024 (TTM): -โ‚น6.39 Billion

According to Affimed 's latest financial reports the company's current earnings are โ‚น0.96 Million. In 2023 the company made an earning of -โ‚น10.66 Billion a decrease over its 2022 earnings that were of -โ‚น8.42 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Affimed from 2013 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -โ‚น6.39 Billion-40.1%
2023 -โ‚น10.66 Billion26.6%
2022 -โ‚น8.42 Billion36.51%
2021 -โ‚น6.17 Billion38.05%
2020 -โ‚น4.47 Billion33.51%
2019 -โ‚น3.35 Billion54.17%
2018 -โ‚น2.17 Billion-32.35%
2017 -โ‚น3.21 Billion-3.51%
2016 -โ‚น3.33 Billion60.24%
2015 -โ‚น2.08 Billion3296.68%
2014 -โ‚น61.06 Million-98.1%
2013 -โ‚น3.22 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Repligen
RGEN
โ‚น2.84 B-140.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Merrimack Pharmaceuticals
MACK
-โ‚น0.21 Billion-97.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
โ‚น13.99 B-297.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
-โ‚น25.19 Billion 255.38%๐Ÿ‡บ๐Ÿ‡ธ USA